Page last updated: 2024-11-04

sennoside a&b and Pancreatic Neoplasms

sennoside a&b has been researched along with Pancreatic Neoplasms in 1 studies

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, SY1
Kim, W1
Lee, YG1
Kang, HJ1
Lee, SH1
Park, SY1
Min, JK1
Lee, SR1
Chung, SJ1

Other Studies

1 other study available for sennoside a&b and Pancreatic Neoplasms

ArticleYear
Identification of sennoside A as a novel inhibitor of the slingshot (SSH) family proteins related to cancer metastasis.
    Pharmacological research, 2017, Volume: 119

    Topics: Actin Depolymerizing Factors; Actins; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Human

2017